First-in-class therapies designed to reprogram the immune system


We are a group of dedicated scientific, medical, and business professionals who are driven to find treatments and cures of immune-mediated diseases. By focusing our research on the root cause of disease we seek to provide treatments previously unavailable to doctors and their patients.

COUR Nanoparticle Platform: CNP

  • Reprograms the immune system
  • Induces tolerance to specific antigens
  • Preserves all immune functionality

Inducing immune tolerance in autoimmune and allergic diseases:

Rare Disease

  • Myasthenia Gravis
  • Pemphigus Vulgaris

Celiac Disease

COUR is rapidly advancing its pipeline of first-in-class therapies for immune-mediated diseases

Celiac Disease (CNP-101/TAK-101) Peanut Allergy (CNP-201) Primary Biliary Cholangitis (CNP-104) Gene Therapy (CNP-AAVC) Full View